Book Value Per Share: The amount of equity available to shareholders expressed on a per common share basis. Calculated as: Total Shareholders Equity / Common Shares Outstanding
Cardiff Oncology, Inc. (CRDF) had Book Value Per Share of $0.51 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$0.04M |
|
$-12.35M |
|
-- |
|
$0.04M |
|
$12.89M |
|
$-12.85M |
|
$0.51M |
|
$-12.35M |
|
$-12.35M |
|
$-12.35M |
|
$-12.35M |
|
$-12.35M |
|
$-12.35M |
|
$-12.85M |
|
$-12.86M |
|
68.35M |
|
68.35M |
|
$-0.18 |
|
$-0.18 |
|
| Balance Sheet Financials | |
$47.34M |
|
$0.49M |
|
$1.83M |
|
$49.17M |
|
$14.46M |
|
-- |
|
-- |
|
$14.46M |
|
$34.71M |
|
$34.71M |
|
$34.71M |
|
68.37M |
|
| Cash Flow Statement Financials | |
$-12.29M |
|
$3.26M |
|
$0.10M |
|
$17.47M |
|
$8.54M |
|
$-8.93M |
|
$1.66M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.27 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-31341.46% |
|
-31341.46% |
|
-- |
|
-30109.75% |
|
-30124.39% |
|
$-12.29M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.21 |
|
419.27 |
|
-35.57% |
|
-35.57% |
|
-25.11% |
|
-35.57% |
|
|
Book Value Per Share |
$0.51 |
$-0.18 |
|
$-0.18 |
|